@misc{10498/40732, year = {2026}, month = {5}, url = {http://hdl.handle.net/10498/40732}, abstract = {Metabolic dysfunction-associated liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is characterized by a pathologic accumulation of triglycerides in the liver which is often observed in the setting of overnutrition. The hepatocellular mechanisms controlling hepatic lipogenic rates are still unclear and advances in understanding these mechanisms are critical to the development of targeted therapies. Long-chain acyl-CoA synthetases (ACSL) catalyze the esterification of fatty acids to CoA to form acyl-CoA, which is an obligatory step in the metabolism of fatty acids. The ACSL5 isoform is highly expressed in human and murine livers and evidence from in vitro studies suggests that this enzyme promotes the synthesis of acyl-CoA pools to be used as substrates in lipogenic metabolic pathways. However, the true contributions of ACSL5 in the liver remain unclear. The present study was designed to elucidate the contribution of ACSL5 to the onset of MASLD in response to overnutrition. We hypothesized that ACSL5 function in the liver to direct acyl-CoA towards lipid synthesis, thereby promoting hepatic triglyceride accumulation and VLDL-triglyceride secretion. Acsl5 liver-specific knockout mice (Acsl5 L-KO) were generated via AAV-CRISPR/Cas9 gene editing (5 x 1011GC/mouse). Animals injected with AAV-CRISPR/Cas9 without gRNA were used as controls. Mice (8-12/group; 50% females) were fed either a chow or a high fat diet (60% kcal from fat) for 12 w. Liver-specific disruption of ACSL5 did not change body weight gain in chow-fed or high-fat diet fed mice. Liver weights, plasma ALT levels, and histological features also remained normal. Liver and plasma lipid concentrations remained unchanged in Acsl5 L-KO male and female mice fed a control chow diet. However, when fed a high-fat diet, plasma levels of triglyceride and phospholipid were decreased (26 and 22% decreases, respectively) in Acsl5 L-KO male mice compared to control mice, and hepatic triglyceride concentrations were decreased by 66% in Acsl5 L-KO female mice compared to their counterparts. The reduction in plasma and liver lipids in high-fat-fed Acsl5 L-KO mice could not be explained by increased fatty acid oxidation as the livers from these animals did not exhibit alterations in lipid oxidative rates. Nonetheless, we observed a 63% decrease in the transcriptional levels of Pcsk9, which a key protein in the regulation of lipoprotein metabolism, in the livers of Acsl5 L-KO male mice fed high-fat diet. Our findings suggest a novel role of hepatic ACSL5 in promoting hepatic triglyceride secretion into the plasma under conditions of excess caloric intake. This reveals a new rationale for targeting ACSL5 in the management of MASLD-associated hypertriglyceridemia.}, publisher = {Elsevier}, keywords = {Fatty liver}, keywords = {triglyceride metabolism}, keywords = {fatty acid metabolism}, title = {Acyl-CoA-synthetase-mediated regulation of hepatic lipid metabolism}, doi = {10.1016/j.jbc.2026.112465}, author = {Alves Bezerra, Michele}, }